Anxiety before surgery and during chemotherapy Mental and Behavioural Disorders
Conditions
Interventions
Method of Randomization: via REDcap
Part I:
1. Ambulatory vs stationary (x2)
2. Suspected or diagnosed cancer vs benign (x2)
3. Aged 18-59 years vs 60+ years (x2)
Part II:
1. Chemo (single agent an
all participants can choose one out of three 4K high-resolution videos available based on their interest. The three videos available contain relaxing nature scenes (landscapes and animals) on either s
Sponsors
Frauenklinik Inselspital Bern
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Female gender 2. Aged 18 years or older 3. Scheduled for elective gynaecological surgery (arm I) or IV cancer treatment (arm II) 4. Absence of severe visual or mental impairments 5. Willing and able to consent 6. No epilepsy or depression or anxiety disorder
Exclusion criteria
Exclusion criteria: 1. Aged below 18 years 2. Severe motion sickness 3. Pre-existing epilepsy, depression or anxiety disorder 4. Significant respiratory disease requiring continuous oxygen administration 5. Medical conditions requiring intensive medical care 6. Inability to wear the VR device 7. Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anxiety measured by the Hamilton Anxiety Score Hospital Anxiety and Depression Scale (HADS) before and after the VR intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Anxiety measured by the Amsterdam Preoperative Anxiety and Information Scale (APAIS) before and after the VR intervention 2. Anxiety measured by Visual Analogue Scales for Anxiety (VAS-A) before and after the VR intervention 3. Stress in arm I measured by cortisol sputum levels before and after the VR intervention 4. Side effects of chemotherapy measured by anamnesis 3 days after the VR intervention | — |
Countries
Switzerland
Contacts
Public ContactFlurina Saner
Outcome results
None listed